Fifth Third Bancorp’s Adicet Bio ACET Stock Holding History

Fifth Third Bancorp’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9	Closed	-$818	–	2609
2023 Q1	$818	Hold	9	–	–	﹤0.01%	2660
2022 Q4	$1.27K	Hold	9	–	–	﹤0.01%	2499
2022 Q3	$2K	Hold	9	–	–	﹤0.01%	2387
2022 Q2	$2K	Hold	9	–	–	﹤0.01%	2405
2022 Q1	$3K	Hold	9	–	–	﹤0.01%	2416
2021 Q4	$2K	Hold	9	–	–	﹤0.01%	2527
2021 Q3	$1K	Hold	9	–	–	﹤0.01%	2543
2021 Q2	$1K	Hold	9	–	–	﹤0.01%	2370
2021 Q1	$2K	Hold	9	–	–	﹤0.01%	2288
2020 Q4	$2K	Buy	+9	New	+$1.84K	﹤0.01%	2199
2019 Q4	–	Sell	-9	Closed	-$9K	–	2202
2019 Q3	$9K	Buy	+9	New	+$10K	﹤0.01%	1810

Other funds holding ACET

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Fifth Third Bancorp's ACET Position: Q2 2023 in Review

Fifth Third Bancorp sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 9 shares — an estimated $818 sold.

Fifth Third Bancorp first reported a position in ACET in Q3 2019 and held it in 11 quarters. The position peaked at $9K in Q3 2019. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

Fifth Third Bancorp reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
Fifth Third Bancorp sold 9 Adicet Bio shares in Q2 2023, an estimated $818.
Fifth Third Bancorp first reported a position in Adicet Bio in Q3 2019 and held it in 11 quarters.
Fifth Third Bancorp's Adicet Bio position peaked at $9K in Q3 2019.
94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on Fifth Third Bancorp's 13F filing for Q2 2023, filed 26 Jul 2023.